MIT researchers find new immunotherapeutic targets for glioblastoma
December 11, 2025
December 11, 2025
CAMBRIDGE, Massachusetts, Dec. 11 -- The Massachusetts Institute of Technology posted the following news:
* * *
MIT researchers find new immunotherapeutic targets for glioblastoma
*
Glioblastoma is the most common form of brain cancer in adults, and its consequences are usually quick and fatal. After receiving standard-of-care treatment (surgery followed by radiation and chemotherapy), fewer than half of patients will survive longer than 15 mon . . .
* * *
MIT researchers find new immunotherapeutic targets for glioblastoma
*
Glioblastoma is the most common form of brain cancer in adults, and its consequences are usually quick and fatal. After receiving standard-of-care treatment (surgery followed by radiation and chemotherapy), fewer than half of patients will survive longer than 15 mon . . .